psychedelics
-
healthTrump's Psychedelics Order: Symbolic Gesture or a Real Shift?
Analysts weigh in on former President Trump's executive order aimed at accelerating psychedelic treatments for mental illness, questioning its practical impact versus symbolic value.
-
healthPhilanthropist's Legacy Fuels Groundbreaking Mental Health Research at University of Calgary
Calgary businessman Norm Johnson's life and openness about mental health challenges inspire significant research into trauma and brain injury treatments at the University of Calgary.
-
healthTrump's Psychedelic Therapy Push: What You Need to Know
President Trump signs an executive order to fast-track research and FDA approval for psychedelic therapies, sparking debate on mental health treatment and patient safety.
-
healthTrump Greenlights Expedited Access to Psychedelic Drug Treatments
President Trump signs an executive order fast-tracking FDA review for psychedelic drugs like ibogaine, allocating $50 million for federal research into potential PTSD and substance abuse treatments.
-
healthScientists Engineer Tobacco Plant to Produce 5 Psychedelic Compounds Simultaneously
Researchers at the Weizmann Institute have engineered a tobacco plant to produce five psychedelic compounds, offering a new avenue for therapeutic research and production.
-
healthDMT Shows Antidepressant Promise in Small Clinical Trial
A small clinical trial suggests the hallucinogen DMT may be an effective antidepressant, offering hope for new treatment options.